Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Late annual account NBB
Fiscal year 2021 was filed 184 days after the legal deadline.
-
Legal situation KBO
Gerechtelijke ontbinding of nietigheid according to the CBE.
Financials
Financial year 2021
PUR THERAPIES from Sivry-Rance, company number BE0827376049, closed financial year 2021 with a result of € -5,554 after tax. For that financial year PUR THERAPIES recorded a gross margin of € -3,503 and equity of € 428,053. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 31, 2023.
€ 428,053
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -5,554
Profit after tax over the fiscal year.
€ 267,278
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 228,053.
Debts at end 2021
€ 176,980
€ 21,200 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 2,080
Supplier invoices still open on the last day of the fiscal year.
€ 108,509
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to PUR THERAPIES?
What happened at PUR THERAPIES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
PUR THERAPIES is active according to the CBE. Legal situation: Gerechtelijke ontbinding of nietigheid.
- New annual accounts for financial year 2021: loss of € 5,554. filed late Source: NBB ↗
- DANIEL PAKULA became a director. NBB
- CLAIRE HOFFMANN became a director. NBB
- New establishment in Schaarbeek. KBO
- Start of the company according to the CBE. KBO
A new publication or filing at PUR THERAPIES? We notify you, reason included.
Follow PUR THERAPIESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PUR THERAPIES are DANIEL PAKULA and CLAIRE HOFFMANN.
Directors
According to the 2021 annual accounts
DANIEL PAKULA
Managing director
since 2020
CLAIRE HOFFMANN
Director
since 2010
Establishments
Establishment units
Physical locations of this company
Rue de la Bretagne 1
6470 Sivry-Rance
Kapucijnbloemenlaan 14
1030 Schaarbeek
Active since 30 June 2010
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0827.376.049
- VAT number
- BE 0827.376.049
- Registered office
- Rue de la Bretagne 1, 6470 Sivry-Rance
- Names & denominations
- PUR THERAPIES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Gerechtelijke ontbinding of nietigheid
- Start date
- 30 June 2010
- Peppol
- Not registered